Overview of Urgent PC Info
Unfortunately, most of the numbers involving overactive bladder (OAB) are frustrating – and most OAB patients are frustrated. Millions of Americans suffer from OAB, yet around 80 percent of OAB patients won’t find relief with OAB medications. Even when medications help, many patients discontinue use within the first year, either because of limited improvement, or irritating side-effects. Fortunately, the Urgent PC Neuromodulation System is available to deliver percutaneous tibial nerve stimulation therapy (PTNS) to OAB patients who don’t respond to other treatments.
Urgent PC is a non-invasive, office-based OAB treatment that provides proven results without harsh drugs or severe side-effects. To better understand its advantages, here is an overview of Urgent PC “By The Numbers.”
Systematic reviews of the OAB literature show consistent success for PTNS.
The meta-analysis conducted by Burton et al. showed a pooled subjective success rate of 61.4 percent across four studies, and a pooled objective success rate of 60.6 percent across seven PTNS studies.
MacDiarmid and Staskin performed a meta-analysis of seven studies, involving 244 patients, and found:
- Voids per day improved 23 percent
- Voids per night improved 41 percent
- Voiding volume improved 43 percent
- Incontinence episodes improved 45 percent
For even more Urgent PC success stats, click here.
A host of studies demonstrate how Urgent PC provides a great balance of strong improvement rates along with limited side-effects.
Even in the very early clinical studies, Urgent PC delivered excellent results with very little risk. In the Investigational Device Exemption (IDE) study, 14 percent of patients had side-effects but all of them were transient and non-serious.
We’ve seen even lower rates of side-effects in more recent studies, including the The SUmiT Trial (Study of Urgent PC vs. Sham Effectiveness in the Treatment of Overactive Bladder), STEP study (Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation), and the OrBIT study (Overactive Bladder Innovative Therapy Trial):
Urgent PC Side-Effects in Key Publications
|Mild pain at stimulation site||0-6%|
|Swelling – leg or foot||0-6%|
|Mild bleeding – needle site||0-4%|
|Moderate pain – stimulation site||1-4%|
|Inflammation – needle site||0-3%|
|Bruising – needle site||0-2%|
For even more on the side-effects comparison, click here.
Clinical trials and studies clearly show that Urgent PC is an effective, non-invasive treatment for OAB patients. Still, because the treatment involves retraining the bladder and mind to act differently, it takes some time to see full results. In other words, your patients will need a little patience.
- 12 Treatments
The initial treatment plan calls for twelve, weekly, half-hour office visits. Patients should receive all twelve treatments before deciding whether or not the treatment is working.
- 6-7 Weeks Until Improvement
Many patients start to see improvements after six weeks of treatment. However, many patients respond later. In fact, although one study showed the average patient responded after 6 treatments, it also showed that a substantial number of patients achieved treatment success between weeks 8 and 12 of therapy.
It’s also important to understand that for many patients the full impact isn’t recognized until the end of the treatment cycle. Data from the trial showing Urgent PC compared to Sham shows the most significant improvement in OAB symptoms, regardless of age or gender, occurs between weeks 7 and 13.
For more on managing the Urgent PC treatment schedule, click here.
Know Your Codes
Urgent PC is now reimbursed as a treatment for Overactive Bladder by all Medicare Contractors (MACs) and also by many private insurance companies. Like all medical procedures, though, reimbursement requires special care to make sure patient documentation and reimbursement procedures are completed properly.
The CPT® code for Urgent PC is 64566 which has the description of, “Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming.”
In addition, payer medical policies often indicate which ICD codes support medical necessity.
These new ICD-10CM codes go into effect on Oct. 1, 2015.
- N39.41 Urge Incontinence
- R35.0 Frequency of Micturition
- R39.15 Urgency of Urinary
For more on codes, reimbursement tools, and how to handle denials and appeals, click here.
Urgent PC is indicated for the treatment of Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Treatment with Urgent PC is contraindicated for patients with pacemakers or implantable defibrillators, patients prone to excessive bleeding, patients with nerve damage that could impact either percutaneous tibial nerve or pelvic floor function or patients who are pregnant or planning to become pregnant during the duration of the treatment. Most patients don't experience side-effects. If side-effects occur, they are typically temporary and include mild pain and skin inflammation at or near the stimulation site. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For complete instructions for use, storage, warnings, indications, contraindications, precautions, adverse reactions and disclaimer of warranties, please refer to the insert accompanying each product or online at www.cogentixmedical.com. Urgent PC is a registered trademark of Cogentix Medical © 2015 Cogentix Medical. All rights reserved.